Oligonucleotide therapies for nonalcoholic steatohepatitis

• Main Authors: Sixu Li (Author), Feng Xiong (Author), Songbo Zhang (Author), Jinghua Liu (Author), Guangping Gao (Author), Jun Xie (Author), Yi Wang (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Nonalcoholic steatohepatitis (NASH) represents a severe disease subtype of nonalcoholic fatty liver disease (NAFLD) that is thought to be highly associated with systemic metabolic abnormalities. It is characterized by a series of substantial liver damage, including hepatocellular steatosis, inflamma...